Massive hemoptysis two months after an otherwise mild SARS-CoV-2 disease (COVID-19) treated with bronchial artery embolization - A case report

Gernot Rott; Frieder Boecker; Clemens Maurer; Timur Sellmann

doi:10.1016/j.radcr.2021.12.048

Massive hemoptysis two months after an otherwise mild SARS-CoV-2 disease (COVID-19) treated with bronchial artery embolization - A case report

Radiol Case Rep. 2022 Mar;17(3):918-921. doi: 10.1016/j.radcr.2021.12.048. Epub 2022 Jan 15.

Authors

Gernot Rott¹, Frieder Boecker², Clemens Maurer³, Timur Sellmann⁴

Affiliations

¹ Department of Radiology, Bethesda-Hospital, Heerstr. 219, Duisburg, 47053, Germany.
² Institute of Clinical Radiology, Lukas-Hospital, Neuss, Germany.
³ Department of Pneumology, Bethesda-Hospital, Duisburg, Germany.
⁴ Department of Anaesthesiology and Intensive Care Medicine, Bethesda-Hospital, Duisburg, Germany.

Abstract

An otherwise healthy young man presented with massive hemoptysis 2 month following a mild coronavirus disease 2019 (COVID-19) and with no other identifiable cause of illness. The patient was successfully treated with bronchial artery embolization. We are strongly convinced that hemoptysis in this case was COVID-related. This unusual case of delayed COVID-related hemoptysis reveals new aspects in the understanding of mid-term and presumable auto-immune triggered effects in patients with initially only mild symptoms of the disease.

Keywords: Bronchial artery embolization; COVID-19; Coronavirus disease 2019; Hemoptysis.

Publication types

Case Reports